First Graduate of FAU-Max Planck Degree Program
Brati Das, 32, recently became the first student approved to graduate with 麻豆精品视频's Integrative Biology and Neuroscience (IBAN) degree.
Eight 麻豆精品视频High Students to Also Earn College Degrees
麻豆精品视频's spring commencement ceremonies highlights the accomplishments of eight 麻豆精品视频High School students.
State Farm Grant to Provide Financial Literacy Education
FAU's Center for Economic Education within the College of Business has received $5,000 from State Farm to supply financial literacy educational materials and workshops for local area educators.
Nursing Students, Faculty Offer Helping Hand to Feet in Need
Among the many health issues that negatively impact the homeless, issues related to their feet are ever present and often left untreated resulting in significant health risks and decreased quality of life.
Words To Assure Protection for Whistleblowers Can Evoke Fear
New study finds that vivid language intended to assure potential whistleblowers they will be protected from retaliation is instead likely to evoke fear and make them less likely to report misconduct.
麻豆精品视频Wave Competition Announces Winners
麻豆精品视频's Division of Research recently hosted a celebratory event for the inaugural 麻豆精品视频Wave Competition, an undergraduate research and entrepreneurial contest.
Senator Joe Negron Visits FAU's College of Business
Florida's incoming Senate President Joe Negron visited 麻豆精品视频's College of Business on the last day of his four-day tour of the state university system.
麻豆精品视频Hosts First U.S. Clinical Trial for Lewy Body Dementia
There are currently no medications available to specifically treat Lewy Body dementia (LBD). FAU's College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for LBD.
Steven D. Roper Named Founding Executive Director
Steven D. Roper, Ph.D., has been appointed as the founding executive director of the Peace, Justice and Human Rights Initiative at 麻豆精品视频.
Researcher Receives NIH Grant for MS and Cancer Treatment
A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.